Was this mentioned in the last investor meet? There has been increased interest since last week.
Also, what are some of the risks currently? Their FDA trials (phase 3) have been successful so far, and 90% complete. Once the trials get completed, what would be the expected timeline for revenue to start hitting company books?
| Subscribe To Our Free Newsletter |
